All Posts: hematology

• Veterans Exposed to Agent Orange May Be at Increased Risk of Developing Progressive Blood Cancers

  Research conducted at Georgetown University’s Lombardi Comprehensive Cancer Center and the Washington DC VA Medical Center on a database of veterans exposed to Agent Orange found an association for an increased risk of developing myeloproliferative neoplasms (MPNs), which are acquired stem cell disorders that can lead to overproduction of mature blood cells complicated by an increased risk of blood clots in arteries and veins. When MPNs progress, they can become deadly leukemias.

  Category: News Release Tags: agent orange, blood cancer, cancer, cancer research, hematology, research, veterans' health

• Drug Found to be Effective in Difficult to Treat Autoimmune Blood Disorder

  Patients taking efgartigimod, a drug being studied for use to treat chronic primary immune thrombocytopenia (ITP), exhibited a significantly greater improvement in platelet counts which are essential to clotting and stopping bleeding, compared to those taking a placebo, according to results reported from the ADVANCE IV clinical trial, which was conducted globally, including at Georgetown University Medical Center.

  Category: News Release Tags: bleeding disorders, hematology, ITP, research